Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its once-monthly dual GLP-1/ GIP receptor agonist, finishing (PDF) p...

Daiichi spends Merck $170M to form bronchi cancer cells T-cell engager pact

.Merck &amp Co. has actually quickly made back a few of the costs of its own Harp on Rehabs buyout, ...

BioMarin stops preclinical gene treatment for heart disease

.After BioMarin carried out a springtime clean of its pipeline in April, the business has actually d...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks work

.Major Pharmas continue to be caught to the suggestion of molecular glue degraders. The latest busin...

Life science credit agency reveals along with $600M

.A brand-new global lifestyle science credit score firm, dubbed Symbiotic Financing, has increased m...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more large wager from the Caforio era, terminating an of...

Nuvation halts BET prevention after looking at period 1 data

.After taking a look at phase 1 data, Nuvation Bio has made a decision to stop focus on its own sing...

' Medical instinct' led FDA experts to support Zevra's unusual condition med

.Zevra Therapeutics' uncommon disease drug seems to be on the pathway to confirmation this fall afte...

Pfizer takes $230M struck after axing neglected DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy breakdown has gone a $230 million...

AC Immune views 'site' potential in Alzheimer's medication data

.After greater than twenty years of work with neurodegenerative diseases, Swiss biotech a/c Immune s...